Concepedia

Valentina Burgio

VB

Statistics

Publications

31

Citations

916

H-Index

20

Active since

2018

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Vita-Salute San Raffaele University

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Istituto Oncologico Veneto

University of Cagliari

Valentina Burgio is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

2018–2023

31

Publications

31

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 124 citations · Full text

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Andrea Casadei‐Gardini, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2022 · 123 citations · Full text

, , +8

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

Mara Persano, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2023 · 50 citations · Full text

Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study

Margherita Rimini, Shigeo Shimose, Sara Lonardi et al. · Hepatology Research · 2021 · 44 citations · Full text

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib

Margherita Rimini, Masatoshi Kudo, Toshifumi Tada et al. · ESMO Open · 2021 · 43 citations · Full text

, , +15

Rows per page

1–5 of 31